Apellis Pharmaceuticals Inc (APLS)

33.32 +0.11 (+0.33%) USD  |  NASDAQ  |  Dec 24, 16:00
More

Apellis Pharmaceuticals Free Cash Flow: -205.58M for Sept. 30, 2024

Free Cash Flow Chart

View Free Cash Flow for APLS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Free Cash Flow Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Free Cash Flow Range, Past 5 Years

View Free Cash Flow Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow Benchmarks

View Free Cash Flow Benchmarks
Start Trial
Biogen Inc 1.768B
Biomarin Pharmaceutical Inc 300.88M
Ionis Pharmaceuticals Inc -374.21M
QuidelOrtho Corp -96.80M
Moderna Inc -3.956B

Free Cash Flow Related Metrics

Cash from Operations (Quarterly) 34.10M
Cash from Financing (Quarterly) 2.542M
Free Cash Flow Per Share (Quarterly) 0.2745
Free Cash Flow to Equity (Quarterly) 39.06M
Free Cash Flow to Firm (Quarterly) 43.84M
Free Cash Flow Yield -5.01%